227 related articles for article (PubMed ID: 27030740)
1. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
[TBL] [Abstract][Full Text] [Related]
2. Differential glucose metabolism in mice and humans affected by McArdle disease.
Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J
Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431
[TBL] [Abstract][Full Text] [Related]
3. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
[TBL] [Abstract][Full Text] [Related]
4. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
[TBL] [Abstract][Full Text] [Related]
5. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
6. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
7. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
Fiuza-Luces C; Santos-Lozano A; Llavero F; Campo R; Nogales-Gadea G; Díez-Bermejo J; Baladrón C; González-Murillo Á; Arenas J; Martín MA; Andreu AL; Pinós T; Gálvez BG; López JA; Vázquez J; Zugaza JL; Lucia A
J Physiol; 2018 Mar; 596(6):1035-1061. PubMed ID: 29315579
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
Howell JM; Walker KR; Creed KE; Dunton E; Davies L; Quinlivan R; Karpati G
Neuromuscul Disord; 2014 Feb; 24(2):167-77. PubMed ID: 24309536
[TBL] [Abstract][Full Text] [Related]
9. Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
Real-Martinez A; Brull A; Huerta J; Tarrasó G; Lucia A; Martin MA; Arenas J; Andreu AL; Nogales-Gadea G; Vissing J; Krag TO; de Luna N; Pinós T
Sci Rep; 2019 Mar; 9(1):5116. PubMed ID: 30914683
[TBL] [Abstract][Full Text] [Related]
10. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
11. Muscle diffusion tensor imaging in glycogen storage disease V (McArdle disease).
Rehmann R; Schlaffke L; Froeling M; Kley RA; Kühnle E; De Marées M; Forsting J; Rohm M; Tegenthoff M; Schmidt-Wilcke T; Vorgerd M
Eur Radiol; 2019 Jun; 29(6):3224-3232. PubMed ID: 30560358
[TBL] [Abstract][Full Text] [Related]
12. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
13. Xanthine Oxidase Pathway and Muscle Damage. Insights from McArdle Disease.
Pareja-Galeano H; Santos-Lozano A; Morán M; Sanchis-Gomar F; Alis R; Santalla A; San Juan AF; Díez-Bermejo J; Martín MA; Arenas J; Lucia A
Curr Pharm Des; 2016; 22(18):2657-63. PubMed ID: 26861723
[TBL] [Abstract][Full Text] [Related]
14. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ
Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858
[TBL] [Abstract][Full Text] [Related]
15. [Suspect McArdle disease in muscular pain! A simple test for the detection of glycogen breakdown defect].
Flodmark BT; Ockander L
Lakartidningen; 1995 May; 92(19):2020-3. PubMed ID: 7752745
[No Abstract] [Full Text] [Related]
16. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
[TBL] [Abstract][Full Text] [Related]
17. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
18. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology.
Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M
Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538
[TBL] [Abstract][Full Text] [Related]
19. Permanent muscle weakness in McArdle disease.
Nadaj-Pakleza AA; Vincitorio CM; Laforêt P; Eymard B; Dion E; Teijeira S; Vietez I; Jeanpierre M; Navarro C; Stojkovic T
Muscle Nerve; 2009 Sep; 40(3):350-7. PubMed ID: 19670320
[TBL] [Abstract][Full Text] [Related]
20. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Llavero F; Arrazola Sastre A; Luque Montoro M; Gálvez P; Lacerda HM; Parada LA; Zugaza JL
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
